Gabriela Smit

CRS:

BJMC

Role:

Administrative and Finance

Position:

Senior Research Service Analyst

Email:

gsmit1@jhmi.edu

Ms. Smit is Fiscal Operations Manager at the Johns Hopkins Center for Clinical Global Health Education. She is an experienced financial analyst with more than 2 decades of experience in finance and accounting and more than a decade of experience at Johns Hopkins University, where she has developed and managed federal and non-federal grants and contracts.
 
While at the CCGHE, she has assembled and managed several international teams of investigators from a number of institutions, including JHU, BJGMC (Lakshya, India), UVRI (Rakai, Uganda), and the National Institute for Research in Tuberculosis (Chennai, India). Ms. Smit provided strategic financial and administrative input to support the new JHU entities in India (JHIPL and JHIF). She manages all financial activities within the US, India and is the key contact for JHU-India collaborations with the NIH Grant Office, the JHU Central Administration, and the JHU SOM Office of Research Administration and Business Office.  In October 2016, she received the Johns Hopkins Department of Medicine Staff Recognition Award for outstanding service. Ms. Smit received a Bachelor of Science degree in Finance and Accounting from Babes-Bolyai University of Cluj-Napoca, Romania

Categories

Leadership Committees
CRS
Roles

Clinical Trials

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...

Read More

P2010: Phase III Study of the Virologic Efficacy and Safety...

IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...

Read More

A5322: Long-Term Follow-up of Older HIV-infected Adults in...

The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...

Read More

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More

P2001 (DAIDS ID 12026): Evaluating the Pharmacokinetics,...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

Read More